Burkehill Global Management, LP
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1904549
NEW YORK, NY
Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,521,250
+$7,258,000 QoQ
Shares Held
725,000
+38.1% QoQ
Ownership
0.509%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#49
of 216 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Burkehill Global Management, LP holds $231,675,092 across 66 Biotechnology names. TRVI ranks #1 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
This page
|
725,000 | $13,521,250 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
325,000 | $12,577,500 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
35,000 | $11,717,650 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
250,000 | $10,417,500 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
50,000 | $9,364,000 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
75,000 | $8,600,250 | |
| 7 | CYTK |
Cytokinetics Inc
|
100,000 | $8,519,000 | |
| 8 | IDYA |
IDEAYA Biosciences, Inc.
|
200,000 | $7,454,000 |
All Filings in TRVI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,521,250 | 725,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,263,250 | 525,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,573,000 | 525,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,803,750 | 525,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,871,750 | 525,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||